Trials / Conditions / Wet Age-related Macular Degeneration (wAMD)
Wet Age-related Macular Degeneration (wAMD)
6 registered clinical trials studyying Wet Age-related Macular Degeneration (wAMD) — 4 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | High Dose (HD) Aflibercept Switch in Neovascular Age-related Macular Degeneration (nAMD): to Load or Maintain NCT07129239 | Clinique de Retine de l'est | Phase 3 |
| Not Yet Recruiting | To Evaluate the Safety and Preliminary Efficacy of Intravitreal EXG202 Injection in Patients with Wet (neovasc NCT06888492 | Guangzhou Jiayin Biotech Ltd | EARLY_Phase 1 |
| Not Yet Recruiting | Efficacy and Safety of AL-001 Ophthalmic Injection in Subjects with WAMD NCT06839339 | Beijing Anlong Biopharmaceutical Co., Ltd. | Phase 2 |
| Recruiting | Long-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD NCT06718816 | Beijing Anlong Biopharmaceutical Co., Ltd. | — |
| Active Not Recruiting | Safety and Tolerability of AL-001 Ophthalmic Injection in Subjects with WAMD NCT06707753 | Beijing Anlong Biopharmaceutical Co., Ltd. | Phase 1 / Phase 2 |
| Unknown | Safety Evaluation of China Patients: Long-term Treatment Outcome of Conbercept Ophthalmic Injection in Real Wo NCT03054818 | Chengdu Kanghong Biotech Co., Ltd. | — |